Literature DB >> 22903403

Magnetic and conductive magnetite nanowires by DNA-templating.

Hasan Daw A Mohamed1, Scott M D Watson, Benjamin R Horrocks, Andrew Houlton.   

Abstract

The synthesis of nanowires made of magnetite (Fe(3)O(4)) phase iron oxide was achieved using DNA as a template to direct formation of the metal oxide and confine its growth in two dimensions. This simple solution-based approach involves initial association of Fe(2+) and Fe(3+) to the DNA "template" molecules, and subsequent co-precipitation of the Fe(3)O(4) material, upon increasing the solution pH, to give the final metal oxide nanowires. Analysis of the DNA-templated material, using a combination of FTIR, XRD, XPS, and Raman spectroscopy, confirmed the iron oxide formed to be the Fe(3)O(4) crystal phase. Investigation of the structural character of the nanowires, carried out by AFM, revealed the metal oxide to form regular coatings of nanometre-scale thickness around the DNA templates. Statistical analysis showed the size distribution of the nanowires to follow a trimodal model, with the modal diameter values identified as 5-6 nm, 14-15 nm, and 23-24 nm. Additional scanning probe microscopy techniques (SCM, MFM) were also used to verify that the nanowire structures are electrically conducting and exhibit magnetic behaviour. Such properties, coupled with the small dimensions of these materials, make them potentially good candidates for application in a host of future nanoscale device technologies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903403     DOI: 10.1039/c2nr31559a

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  1 in total

1.  Meso-functionalization of calix[4]arene with 1,3,7-triazapyrene in the design of novel fluorophores with the dual target detection of Al3+ and Fe3+ cations.

Authors:  Timofey D Moseev; Igor A Lavrinchenko; Mikhail V Varaksin; Diana Yu Pobedinskaya; Oleg P Demidov; Ivan V Borovlev; Valery N Charushin; Oleg N Chupakhin
Journal:  RSC Adv       Date:  2021-02-04       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.